resistant to one of the four standard drugs (isoniazid, 
rifampicin, pyrazinamide, and ethambutol). Multidrug 
resistance (resistant to at least isoniazid and rifampicin) 
is found in about 2% of cases, as in our case [1, 12]. In 
addition, literature confirms that articular TB is more 
frequently caused by multidrug-resistant strains [4â€“6]. 
In 2021, 77 cases of multidrug-resistant (MDR) TB were 
recorded in Germany [12].
With regard to therapy, it has been shown that joint 
TB can be treated effectively with an antibiotic therapy 
in accordance with the resistogram [7]. The duration 
of therapy should be adapted to the clinical and radio-